Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
New crypto investors should know key insights to thrive in the market. Equip yourself with the right information for success.
28,386 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
AI-led gains cool as a quintet of warning signs reappear, drawing parallels to the late-2000s Nasdaq run. Investors b...
U.S. equities drift modestly lower as traders await Federal Reserve cues and key data. This stock market live july br...
Many investors worry about a credit squeeze, especially when debt levels rise and lending standards tighten. This gui...
AI-driven payroll reductions accelerate as major firms trim jobs, altering earnings and market sentiment in May 2026.
A revived SpaceX IPO talk targets a multi‑trillion valuation, potentially lifting Elon Musk over $1 trillion in net w...
Palantir maintains AI-driven momentum into 2026, but investors weigh continued growth against contracts and policy ri...
Netflix has stumbled this year, leaving many investors wondering what comes next. This guide explains the drop, what ...
Markets are calm on the surface as oil climbs and regional tensions flare. Yet history suggests a fragile calm, with ...
Amazon’s cash flow story isn’t simple. This guide breaks down what drives cash in and out, what to expect in 2026, an...
IMAX bucked trend as cinema operators fade; investors eye the premium-format chain's sale.
As AI demand drives 24/7 data-center power, investors pivot from solar bets to nuclear plays. The nuclear fund is del...